In this podcast series, the AHA checks in with its Associates to learn how they are supporting members and leveraging the AHA Associate Program to stay connected with members and help them achieve their goals and objectives.

Episode 45: Driving Precision Medicine Adoption Through Genomics 

In this episode, Kathleen Wessel, VP of Business Management and Operations at the AHA, speaks with Dr. James Lu, MD, PhD, Chief Executive Officer & Co-founder of Helix and Dr. Calum MacRae, MD, PhD, Co-Director of Genomic Medicine and Professor of Medicine at Harvard University. Join them as they dive into the rapidly evolving field of genomics and personalized medicine. They will also discuss the positive impact of the growing role of genomics in healthcare, including how it impacts hospital data strategy and ultimately provides better patient care.

Helix

Helix is the leading population genomics and viral surveillance company. Helix enables health systems, public health organizations and life sciences companies to accelerate the integration of genomic data into patient care and public health decision making.

To see a full list of the current AHA Associates like Helix, visit this page.

Featured On This Episode

James Lu, MD, PhD

Chief Executive Officer and Co-founder

Helix

Calum MacRae, MD, PhD

Co-Director of Genomic Medicine, Professor of Medicine

Harvard University

Kathleen J. Wessel

Vice President, Business Management and Operations

American Hospital Association